| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,611,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
6,246,627 |
Avg
Vol: |
2,858,046 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,334 |
174,877 |
|
- |
|
| Duvall Martin J |
SVP, Commercial Operations |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
3,430 |
|
- |
|
| Keane Raymond T |
SVP General Counsel & CCO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
40,681 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
63,207 |
|
- |
|
| Dodion Pierre F |
SVP, Corp. Dev. & Operations |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
44,282 |
|
- |
|
| Berstein David L |
Senior VP, Chief IP Officer |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
191,098 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
97,271 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,334 |
344,706 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,334 |
45,902 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-03-13 |
4 |
AS |
$22.06 |
$1,102,990 |
D/D |
(50,000) |
1,676,089 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-03-13 |
4 |
AS |
$22.07 |
$59,587 |
I/I |
(2,700) |
27,457 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-03-12 |
4 |
AS |
$22.04 |
$1,101,755 |
D/D |
(50,000) |
1,726,089 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-03-12 |
4 |
AS |
$22.04 |
$59,516 |
I/I |
(2,700) |
30,157 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• • – |
2013-03-12 |
4 |
AS |
$22.00 |
$46,310 |
D/D |
(2,105) |
38,568 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-03-04 |
4 |
AS |
$21.00 |
$206,598 |
D/D |
(9,838) |
331,372 |
|
- |
|
| Riedel Norbert G |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
84,359 |
|
- |
|
| Radaelli Massimo |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
68,000 |
|
- |
|
| Lavidas Athanese |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
94,131 |
|
- |
|
| Lamarche Jay R |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
414,705 |
|
- |
|
| Wilson Wayne |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
88,000 |
|
- |
|
| Whelan Jr. Robert M. |
Director |
• • – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
32,359 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-01-15 |
4 |
OE |
$4.49 |
$292,414 |
D/D |
57,939 |
341,210 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2013-01-02 |
4 |
AS |
$20.08 |
$501,890 |
D/D |
(25,000) |
166,543 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2012-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
450,000 |
1,776,089 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2012-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
450,000 |
248,745 |
|
- |
|
703 Records found
|
|
Page 16 of 29 |
|
|
